Headquartered in Boston, MA Fiscal year ends September NYSE: CBT cabotcorp.com
Cabot Corporation (NYSE: CBT) is a global specialty chemicals and performance materials company. It operates through two primary business segments: Reinforcement Materials and Performance Chemicals. The company is a provider of reinforcing carbons, specialty carbons, battery materials, engineered elastomer composites, inkjet colorants, masterbatches and conductive compounds, fumed metal oxides, and aerogel. The Reinforcement Materials segment serves primarily the tire and industrial rubber products industries, while Performance Chemicals encompasses specialty carbons, fumed metal oxides, and a growing battery materials product line that supplies conductive additives to global battery manufacturers for electric vehicles and battery energy storage systems. Cabot operates globally across the Americas, Asia Pacific, and Europe/Middle East/Africa regions, with manufacturing and sales operations serving diverse end markets including automotive, electronics, energy storage, and industrial applications. Updated
Wednesday's top analyst upgrades and downgrades included Advanced Micro Devices, Apple, AT&T, Cenovus Energy, Dollar General, Dynatrace, FedEx, Molson Coors Beverage, NiSource, Uber Technologies and Vale.
Tuesday's top analyst upgrades and downgrades included Ally Financial, Amgen, Baidu, Bilibili, Bill.com, Coinbase Global, Eli Lilly, GE Healthcare Technologies, JPMorgan Chase, Merck, Moderna, Newmont, Palo Alto Networks, Truist Financial and Viking…
Wednesday’s additional top analyst upgrades and downgrades were on Home Depot, Intel, Lincoln National, Marvell Technology, Medtronic, Microchip Technology, Nvidia, NXP Semiconductors, ON Semiconductor and more.
Thursday's top analyst upgrades and downgrades included Coinbase Global, Continental Resources FedEx, Lam Research, Olin, Planet Labs, Sonos, Southwestern Energy, Spotify Technology, Tapestry and Wheels Up Experience.
Friday's top analyst upgrades and downgrades included American Airlines, Boston Beer, CarMax, Danaher, Domino’s Pizza, D.R. Horton, Monster Beverage and Starbucks.
Celanese, First Hawaiian, Peloton Interactive, Qorvo and Zip Recruiter were included among the Thursday afternoon analyst upgrades and downgrades.
Monday's top analyst upgrades and downgrades included Albermarle, Biogen, Dun & Bradstreet, eBay, First Solar, Lemonade, Morgan Stanley, Procter & Gamble, Schlumberger and Verizon Communications.
Friday's top analyst upgrades, downgrades and initiations included Cardinal Health, Domino's, FedEx, Ford, General Electric, Grubhub, HSBC, Marvell Technology, Twitter and Uber.
Thursday's top analyst upgrades, downgrades and initiations included American Airlines, Apple, Bed Bath & Beyond, Box, Cisco, HP, Kroger, Netflix, PG&E and UnitedHealth.
The top analyst upgrades, downgrades and initiations seen on Monday included Apple, Baker Hughes, Conagra Brands, Facebook, General Electric, Halliburton, Petrobras, Schlumberger, Vodafone and Walmart.
While there is absolutely no guarantee that these energy companies will be acquired, they are outstanding stocks to own in aggressive growth portfolios on their own.
These five stocks come with upward earnings revisions and the potential for rising dividends. They all make good sense for investors looking for stocks ideas as we get closer to the second…
The top analyst upgrades, downgrades and initiations seen on this Monday morning include Alphabet, Exelon, Kinross Gold, Noble, Potash, Seagate Technology and Western Digital.
The chemicals industry is not ordinarily thought of as action central, but there have been some recent moves, including one today, that are stirring things up. Two private equity firms, First Reserve…
Active traders and day traders have many stocks to choose from this Thursday morning. We are tracking news and moves in shares of Apple, Inc. (NASDAQ: AAPL), Cabot Corporation (NYSE: CBT), TiVo, Inc. (NASDAQ: TIVO).…
Cabot Corporation (NYSE: CBT) is a global specialty chemicals and performance materials company. It operates through two primary business segments: Reinforcement Materials and Performance Chemicals.
24/7 Wall St.'s 12-month price target for CBT is $89.56, rated Buy. The Wall Street consensus target is $90.33. CBT price prediction →
